Collegium Pharmaceutical, Inc. announces an Equity Buyback for $150 million worth of its shares.

Published: 2025-07-07 09:36:22 ET COLL

Published on 07/07/2025 at 09:36

Collegium Pharmaceutical, Inc. (NasdaqGS:COLL) announces a share repurchase program. Under the program, the company will repurchase up to $150 million worth of its own shares. The company to utilize existing cash on hand to fund the share repurchase program.

The program will expire on December 31, 2026.